JP2004217610A - Treatment of cancer, diabetes, leukemia and insomnia, and promotion of rejuvenation, cell activation and immunocyte proliferation by physiological saline comprizing deuterium-depleted water - Google Patents
Treatment of cancer, diabetes, leukemia and insomnia, and promotion of rejuvenation, cell activation and immunocyte proliferation by physiological saline comprizing deuterium-depleted water Download PDFInfo
- Publication number
- JP2004217610A JP2004217610A JP2003040375A JP2003040375A JP2004217610A JP 2004217610 A JP2004217610 A JP 2004217610A JP 2003040375 A JP2003040375 A JP 2003040375A JP 2003040375 A JP2003040375 A JP 2003040375A JP 2004217610 A JP2004217610 A JP 2004217610A
- Authority
- JP
- Japan
- Prior art keywords
- deuterium
- water
- cancer
- physiological saline
- diabetes
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Description
【0001】
【発明の属する技術分野】
本発明は、癌、糖尿病、白血病、不眠症の治療および若返り、細胞の活性化、免疫細胞の増加の促進を行う。重水素減少水(スーパーライトウォーター)を原料とした生理的食塩水を点滴で体内に注入することによっておこなうものである。
【0002】
【従来の技術】
一般に老人になるとメラトニンが出なくなり、眠りが浅く従って睡眠中に作られるNK細胞も少なくなり、癌、糖尿病、白血病、不眠症の治療は外科手術、放射線治療、投薬治療などで対処するのが通常であるが、この場合、当人が病院や診療所に直接行って治療を受ける。
【0003】
また、若返り、細胞の活性化、免疫細胞の増加に効果がある健康食品が多数販売されている昨今において、さまざまな健康食品を入手して体質改善をする対象者が増えている。
【0004】
【発明が解決しようとする課題】
しかしながら現実において、従来の治療や健康食品による体質改善が治療として成果が上がらないことがあり、DNAの複製に失敗した異常細胞は、シミ、血管種であるあざ、いぼ、しわ、老人班、癌、糖尿病の原因となり、ベーター細胞の複製失敗細胞は、体内のあらゆる細胞の複製失敗細胞を作り出す。
【0005】
【課題を解決するための手段】
本発明者等は係る課題を解決するために鋭意研究したところ、癌、糖尿病、白血病、不眠症の治療および若返り、細胞の活性化、免疫細胞の増加の促進のための重水素減少水(スーパーライトウォーター)を原料とした生理的食塩水を開発して、本発明を提供するものである。
【0006】
すなわち本発明は癌、糖尿病、白血病、不眠症の治療および若返り、細胞の活性化、免疫細胞の増加の促進に最適な重水素減少水(スーパーライトウォーター)を飲用や重水素減少水(スーパーライトウォーター)を原料とした生理的食塩水を点滴により体内に注入し、体内の重水素濃度を低下させることを特徴とする癌、糖尿病、白血病、不眠症の治療および若返り、細胞の活性化、免疫細胞の増加の促進方法であり、新陳代謝が活発になるとホルモンの分泌が良くなり、脳内ホルモン(メラトニン)が分泌され深い良質の睡眠が取れる。睡眠によりNK細胞が増加し異常細胞を除去して正常細胞を複製し若返る。
【0007】
【発明の実施の形態】
本発明は重水素減少水(スーパーライトウォーター)を飲用や点滴で体内に注入しより効果的に体内の重水濃度を低下させる。
【0008】
重水素濃度が149ppm以下になるとたんぱく質結合が弱くなり、新陳代謝が高まり分解しやすくなる。結合が弱くなった癌細胞をNK細胞や抗癌剤で壊死させる。
【0009】
新陳代謝が高まることにより若返り、細胞の活性化、免疫細胞の増加の促進のこうかがある。
【0010】
【発明の効果】
以上説明したように、本発明によれば重水素濃度149ppm以下の重水素減少水(スーパーライトウォーター)を飲用や重水素減少水(スーパーライトウォーター)を原料とした生理的食塩水を点滴することにより、体内の重水素濃度を低下させることにより、新陳代謝を高め、結合の弱くなったガン細胞をNK細胞や抗癌剤で壊死させることが可能となる。また、新陳代謝が高まることにより若返り、細胞の活性化、免疫細胞の増加の促進の効果がある。[0001]
BACKGROUND OF THE INVENTION
The present invention treats and rejuvenates cancer, diabetes, leukemia, and insomnia, promotes cell activation, and increases immune cells. It is performed by injecting physiological saline using deuterium-reduced water (super light water) as a raw material into the body by infusion.
[0002]
[Prior art]
In general, melatonin does not come out when we become old, and sleep is shallow, so NK cell made during sleep decreases, and treatment of cancer, diabetes, leukemia, insomnia is usually treated by surgery, radiation therapy, medication therapy In this case, however, the person goes directly to the hospital or clinic for treatment.
[0003]
In addition, many health foods that are effective in rejuvenating, activating cells, and increasing immune cells are being sold in recent years, and an increasing number of subjects obtain various health foods to improve their constitution.
[0004]
[Problems to be solved by the invention]
However, in reality, the improvement of constitution by conventional treatments and health foods may not be successful as treatment, and abnormal cells that fail to replicate DNA are spots, blood vessels such as bruises, warts, wrinkles, geriatric groups, and cancer. Due to diabetes, beta cell replication failure cells produce replication failure cells of every cell in the body.
[0005]
[Means for Solving the Problems]
The present inventors have conducted intensive research to solve such problems, and have found that deuterium-depleted water (supermarkets) for the promotion of cancer, diabetes, leukemia, insomnia treatment and rejuvenation, cell activation, and immune cell increase. The present invention is provided by developing physiological saline using light water as a raw material.
[0006]
That is, the present invention relates to deuterium-depleted water (superlight water) that is optimal for the treatment and rejuvenation of cancer, diabetes, leukemia, insomnia, cell activation, and increase of immune cells. Physiological saline using water as a raw material is infused into the body by infusion to reduce the deuterium concentration in the body. Treatment and rejuvenation of cancer, diabetes, leukemia, insomnia, cell activation, immunity It is a method of promoting cell growth. When metabolism is activated, hormone secretion is improved, and brain hormone (melatonin) is secreted, resulting in deep sleep. Sleep increases NK cells, removes abnormal cells, replicates normal cells, and rejuvenates.
[0007]
DETAILED DESCRIPTION OF THE INVENTION
In the present invention, deuterium-reduced water (super light water) is injected into the body by drinking or drip, thereby reducing the concentration of heavy water in the body more effectively.
[0008]
When the deuterium concentration is 149 ppm or less, protein binding is weakened, metabolism is increased, and decomposition is likely to occur. Cancer cells that have weakened binding are necrotized with NK cells or anticancer agents.
[0009]
There is a way to promote rejuvenation, cell activation, and increase in immune cells by increasing metabolism.
[0010]
【The invention's effect】
As described above, according to the present invention, deuterium-reduced water (superlight water) having a deuterium concentration of 149 ppm or less is used for drinking or physiological saline using deuterium-reduced water (superlight water) as a raw material. Thus, by reducing the deuterium concentration in the body, it becomes possible to increase metabolism and to necrotize cancer cells that have become weakly bound with NK cells or anticancer agents. In addition, an increase in metabolism has the effect of rejuvenating, activating cells, and promoting an increase in immune cells.
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2003040375A JP2004217610A (en) | 2003-01-15 | 2003-01-15 | Treatment of cancer, diabetes, leukemia and insomnia, and promotion of rejuvenation, cell activation and immunocyte proliferation by physiological saline comprizing deuterium-depleted water |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2003040375A JP2004217610A (en) | 2003-01-15 | 2003-01-15 | Treatment of cancer, diabetes, leukemia and insomnia, and promotion of rejuvenation, cell activation and immunocyte proliferation by physiological saline comprizing deuterium-depleted water |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2004217610A true JP2004217610A (en) | 2004-08-05 |
Family
ID=32905221
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2003040375A Pending JP2004217610A (en) | 2003-01-15 | 2003-01-15 | Treatment of cancer, diabetes, leukemia and insomnia, and promotion of rejuvenation, cell activation and immunocyte proliferation by physiological saline comprizing deuterium-depleted water |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP2004217610A (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008065734A1 (en) * | 2006-11-27 | 2008-06-05 | Oct Incorporated | Aqueous composition |
CN107811968A (en) * | 2017-12-14 | 2018-03-20 | 官鲁东 | The low deuterium-oxide parenteral solution of application and glucose of the low deuterium-oxide in glucose injection |
US20190224193A1 (en) * | 2013-03-14 | 2019-07-25 | Christopher Brian Reid | Compositions of Natural Extracts and Use Thereof in Methods for Preventing or Treating Diseases |
-
2003
- 2003-01-15 JP JP2003040375A patent/JP2004217610A/en active Pending
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008065734A1 (en) * | 2006-11-27 | 2008-06-05 | Oct Incorporated | Aqueous composition |
US20190224193A1 (en) * | 2013-03-14 | 2019-07-25 | Christopher Brian Reid | Compositions of Natural Extracts and Use Thereof in Methods for Preventing or Treating Diseases |
CN107811968A (en) * | 2017-12-14 | 2018-03-20 | 官鲁东 | The low deuterium-oxide parenteral solution of application and glucose of the low deuterium-oxide in glucose injection |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PL340096A1 (en) | Methods of treating hypercoagulability states or hypoproteinaemia in respect to c protein | |
CN107670044A (en) | Comprising the treatment using magnetic dipole stabilizing solutions or improve disease and strengthen the method for performance | |
JP2004217610A (en) | Treatment of cancer, diabetes, leukemia and insomnia, and promotion of rejuvenation, cell activation and immunocyte proliferation by physiological saline comprizing deuterium-depleted water | |
US6495585B2 (en) | Method for treating hyperproliferative tissue in a mammal | |
CN103977194A (en) | Application of drug for external use capable of effectively treating wound infection in preparing medicaments for treating diabetic foot | |
Fu et al. | Application of dexmedetomidine‐remifentanil in high‐intensity ultrasound ablation of uterine fibroids: a randomised study | |
Castagna et al. | Radio electric tissue optimization in the treatment of surgical wounds | |
WO2009094811A1 (en) | A royal jelly acidic mixture preparation and application thereof | |
KR20100024019A (en) | Multi-purpose food concentrate mineral preparation and preparation method thereof | |
JP2004277391A (en) | Treatment of cancer, diabetes, leukemia and insomnia with sake brewed using deuterium-reduced water and its use for rejuvenation, activation of cells, and acceleration of increase of immunocyte, and production method thereof | |
CN105816598A (en) | Medicine for treating burns and scalds and preparation method thereof | |
JP2006241129A (en) | Method for using tpn(total parenteral nutrition) containing syrup, electrolyte, etc. using superlight water and superlight nutrient | |
US20160068841A1 (en) | Cancer treatment methods using remote conditioning | |
JP2004315488A (en) | Treatment of cancer, diabetes, leukemia and insomnia and rejuvenation, activation of cell and promotion of immunocyte increase by using beer brewed in deuterium-reduced water (super light water) as raw material | |
KR101130617B1 (en) | A funtional drink containing multifuntional mineral complex | |
JP2004357678A (en) | Treatment of cancer, diabetes mellitus, leukemia, aplastic anemia and insomnia, treatment and prevention of severe acute respiratory syndrome (sars), rejuvenation, activation of cell and promotion of increase of immune cell by soy sauce prepared by using deuterium-attrited water (super light water) as raw material, and method for producing the same | |
RU2676836C2 (en) | Device for treatment of immune function deficiency and regulation of metabolism | |
Reipschläger et al. | Combined neodymium-doped yttrium aluminum garnet laser and sclerotherapy in Gorham-Stout syndrome | |
Land | Analysis of the Curative Effect from the Injection of Sclerosing Agent in 1,000 Patients with Vascular Abnormalities | |
Suzuki et al. | Project 4 Clinical research on explorations into new application of BNCT (31P4) | |
RU2508097C1 (en) | Method for multimodality therapy for diabetic foot | |
Medina | Laser therapy and acupuncture | |
JP2004315490A (en) | Therapy for aplastic anemia (myelodysplastic syndrome) with physiological saline solution of deuterium-reduced water (super light water) | |
Tomar et al. | Role of Clonidine in Fascia Iliaca Compartment Block for Preoperative Analgesia in Post Hip Fracture Patients: A Comparative Study | |
Glass et al. | Daily walks can improve digestion, chronic conditions |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20050302 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20080715 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20081118 |